Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030.?This RACGP partnered webinar presented by Dr Anastasia Volovets will provide a clinical update on recent PBS changes to prescribing hepatitis C treatment in a primary care setting, including simplification of treatment options and removal of genotyping.
*This course is for: *General Practitioners prescribing or intending to prescribe s85 direct-acting antiviral medication for HCV in primary care settings.
This event is sponsored by Gilead Sciences. Sponsorship is governed by our Sponsorship Policy. Gilead Sciences has had no input into the content, tone or emphasis of this course. ASHM does not endorse or promote any sponsor’s product or service.
This activity is pending approval by the RACGP.
04 August 2020, 7:00pm – 8:30pm AEST